Investment Tree
You’re a budding entrepreneur with a bright idea and no idea how to fund its commercialisation. Who consistently invests in MedTech, CleanTech or Hi-Tech – the very people with the track records and appetite to back a new play in your chosen segment? Or you’re an established and successful entrepreneur that has made millions out of one venture and want to find a bright young hopeful to invest in – look up the Investment Tree.
-
DeepTech venture builder raises over $3m top-up funding
Cambridge Future Tech, a tech-first venture builder, reports the initial close of a funding round that raised over $3 million – marking a significant... Read More
-
Investors in Harness as Cambridge biotech takes funding to £17.6m
Biotech company Harness Therapeutics in Cambridge has raised an extra £4 million growth capital from existing investors to take its haul to £17.6m to... Read More
-
ImmuONE raises £2m for 3D human lung model to replace animal testing
Two scientists who have developed a 3D human lung model that can assess the safety of new drugs without the use of animal testing have raised £2... Read More
-
Immaterial cleans up with Series A cash to build manufacturing demo plant
University of Cambridge spin-out Immaterial Ltd has completed an undisclosed Series A funding round – just days after winning a major category of the... Read More
-
Kuano funding hits £2.8m with latest haul to fast-track design of nextgen medicines
Kuano, a Cambridge-based drug discovery company combining quantum mechanics with AI to design nextgen medicines, has closed a £1.8 million seed... Read More
-
Funding from US investor underpins global scale-up for Echion Technologies
A big-hitting US investor majoring in transformational technologies that accelerate global energy transition has pumped significant growth capital... Read More
-
M Ventures leads Lightcast Discovery’s $49m Series B raise
Life science tools business Lightcast Discovery – with bases in Cambridge UK and Boston US – has raised a $49 million Series B round. It is a... Read More
-
CellCentric wins $25m from Pfizer for cancer collaboration
Cambridge biotech game-changer CellCentric has secured a strategic investment of $25 million from global biopharma company Pfizer to support the... Read More
-
Camena Bioscience raises $10m scale-up funding
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10 million Series A... Read More
-
Robok takes scale-up funding to $4m
RoboK, a Cambridge startup applying AI-powered computer vision to logistics & industrial workplaces, has clinched a $2.1 million Series A... Read More
-
SMi Systems raises £6m seed funding in charge towards commercialisation
SMi Systems, a US business with Cambridgeshire offices and specialising in single molecule imaging and quantification technologies for biomedical... Read More
-
BIOS Health raises significant funding from Silicon Valley and elsewhere
Cambridge company BIOS Health, a pioneer in the development of AI-driven precision medicine for the nervous system, is set to scale fast after... Read More
-
‘Meat from animal cells’ pioneer raises $30m to target $427bn market
Uncommon – a Cambridge startup manufacturing meat from animal cells – has raised $30 million Series A scale-up funding. The company, formerly... Read More
-
Romp for ZOMP as ZEISS backs £2m seed round
Cambridge University spin-out ZOMP has raised £2m seed cash as it develops new imaging technology for the life science sector. The funding has been... Read More
-
PharmEnable closes $7.5m funding round to scale drug hunt
PharmEnable, a Cambridge drug discovery company focused on chemical novelty, diversity and complexity, has closed a Pre-Series A investment round of... Read More
-
Cyted raises $16.8m funding to scale globally
Early cancer diagnostics company Cyted in Cambridge has raised $16.8 million as part of a Series A funding round set to propel the business into... Read More
-
Amadeus tucks into Tenzo’s $5m bid to supercharge restaurant performance
Tenzo, an AI-powered restaurant PerformanceOps platform, has raised a $5 million Series A round led by Amadeus Capital Partners in Cambridge and S28... Read More
-
NVIDIA investment boost for CHARM Therapeutics
NVentures, the venture investment arm of US tech giant NVIDIA, has injected an undisclosed sum into CHARM Therapeutics – a 3D deep learning biotech... Read More
-
Zetta Genomics maps Series A after clinching extra seed cash
Rapidly scaling genomics data technology startup Zetta Genomics in Cambridge is planning a bumper Series A in 2024 after netting £1.9 million... Read More
-
NoBACZ Healthcare wins £2.7m seed cash for novel wound protection technology
Wound protection specialist, NoBACZ Healthcare – a University of Cambridge spin-out – has secured £2.7 million seed funding. The seed round... Read More